Connect
MJA
MJA

Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality

Paul J Sambrook, B E Christopher Nordin and Alastair N Goss
Med J Aust 2011; 194 (1): . || doi: 10.5694/j.1326-5377.2011.tb04153.x
Published online: 3 January 2011

To the Editor: The article by Philip Sambrook et al on the impact of adverse news media on prescriptions for osteoporosis1 contains a number of serious errors and ignores more recent data.


  • 1 Royal Adelaide Hospital, Adelaide, SA.
  • 2 University of Adelaide, Adelaide, SA.



Competing interests:

Alastair Goss has been a consultant to Merck and Novartis on ONJ, and has provided expert testimony for the plaintiffs in the US class action against Merck with respect to alendronate.

  • 1. Sambrook PN, Chen JS, Simpson JM, March LM. Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality. Med J Aust 2010; 193: 154-156. <MJA full text>
  • 2. Khosla S, Burr D, Cauley J, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007; 22: 1479-1491.
  • 3. Lo JC, O’Ryan FS, Gordon NP, et al. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 2010; 68: 243-253.
  • 4. Mavrokkoki T, Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 2007; 65: 415-423.
  • 5. Stone KL, Seeley DG, Lui LY, et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res 2003; 18: 1947-1954.
  • 6. Boles v Merck & Co. Case no. 06-CV-9455. In re Fosamax products liability litigation, MDL 1789, US District Court, Southern District of New York (Manhattan).

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.